Breaking News - The Fly

Open Search

SHPH

Shuttle Pharmaceuticals

$

()

Shuttle Pharmaceuticals files to sell subscription rights to buy $4.5M in units

SHPH

4/5/2024 - 17:09pm

Shuttle Pharmaceuticals intends to pursue rights offering

SHPH

2/13/2024 - 08:12am

Shuttle Pharmaceuticals approved by FDA for Phase 2 trial of Ropidoxuridine

SHPH

1/8/2024 - 09:09am

Shuttle Pharmaceuticals submits IND application to U.S. FDA for Ropidoxuridine

SHPH

12/11/2023 - 09:06am

Shuttle Pharmaceuticals licenses IP for prostate cancer biomarker program

SHPH

10/31/2023 - 09:03am

Shuttle Pharmaceuticals announces results of pre-IND meeting with FDA

SHPH

9/25/2023 - 09:02am

Shuttle Pharmaceuticals expands patent coverage on HDAC inhibitor platform

SHPH

9/11/2023 - 09:03am

Shuttle Pharmaceuticals' HDAC6 inhibitor shows immune response stimulation

SHPH

8/29/2023 - 09:04am

Shuttle Pharmaceuticals reports working capital balance of $9M as of March 31

SHPH

5/26/2023 - 09:03am